Skip to main content
. 2024 Jul 3;38(4):1891–1899. doi: 10.21873/invivo.13644

Table II. Paclitaxel-ifosfamide based therapy and further salvage therapy.

graphic file with name in_vivo-38-1893-i0002.jpg

aOne patient received the regimen in combination with methotrexate, epirubicin, mitomycin-C, vincristine, cisplatin, leucovorin and 5-fluorouracil (MEMOCLUB); another received a combination of pembrolizumab and lenvatinib; the third patient received lenvatinib alone. bTrial therapy with toripalimab and GHF018.